CNA Diagnostics and Ethos Veterinary Health Enter Strategic Partnership to Develop Suite of Diagnostic Tests for the Companion Animal Market

,
This project seeks to cure canine hemangiosarcoma through advanced diagnostics, personalized medicine, and cancer genomics.

CNA Diagnostics Inc. (“CNAD”) and Ethos Veterinary Health (“Ethos”) are pleased to announce the parties have entered a strategic partnership to develop and distribute a suite of molecular diagnostic tests specifically designed to serve the companion animal market.

Read more…

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply